Lyra Therapeutics (LYRA) Earnings Date, Estimates & Call Transcripts $0.09 0.00 (-0.65%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.09 +0.00 (+0.87%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyra Therapeutics Earnings Summary Lyra Therapeutics issued Q1 2025 earnings on May 6, 2025, reporting an EPS of -$0.12, which beat analysts' consensus estimates of -$0.15 by $0.03. Quarterly revenue was reported to be $0.18 million, above analyst estimates of $0.16 million. With a trailing EPS of -$1.21, Lyra Therapeutics' earnings are expected to grow next year, from ($0.93) to ($0.58) per share. Upcoming Q2 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (May. 6) -$0.15 Actual EPS (May. 6) -$0.12 Beat By $0.03 Actual Revenue (May. 6) $0.18MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)LYRA Upcoming EarningsLyra Therapeutics' next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules. Powered by Get Lyra Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lyra Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLYRA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LYRA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Lyra Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.12-$0.12-$0.12Q2 20251-$0.12-$0.12-$0.12Q3 20251-$0.12-$0.12-$0.12Q4 20251-$0.16-$0.16-$0.16 Lyra Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/6/2025Q1 2025-$0.15-$0.12+$0.03-$0.13$0.16M$0.18M3/13/2025Q4 2024-$0.12-$0.16 -$0.04-$0.16$0.21M$0.21M8/14/2024Q2 2024-$0.34-$0.29+$0.05$0.16$0.43M$0.60M4/30/2024Q1 2024-$0.26-$0.35 -$0.09-$0.35$0.40M$0.53M3/21/2024Q4 2023-$0.33-$0.22+$0.11-$0.22$0.52M$0.15M11/7/2023Q3 2023-$0.33-$0.27+$0.06-$0.27$0.48M$0.54M8/8/2023Q2 2023-$0.44-$0.33+$0.11-$0.30$0.41M$0.46M Lyra Therapeutics Earnings - Frequently Asked Questions When is Lyra Therapeutics's earnings date? Lyra Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on LYRA's earnings history. Did Lyra Therapeutics beat their earnings estimates last quarter? In the previous quarter, Lyra Therapeutics (NASDAQ:LYRA) reported ($0.12) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.03. Learn more on analysts' earnings estimate vs. LYRA's actual earnings. How much revenue does Lyra Therapeutics generate each year? Lyra Therapeutics (NASDAQ:LYRA) has a recorded annual revenue of $1.19 million. How much profit does Lyra Therapeutics generate each year? Lyra Therapeutics (NASDAQ:LYRA) has a recorded net income of -$62.68 million. LYRA has generated -$1.21 earnings per share over the last four quarters. What is Lyra Therapeutics's EPS forecast for next year? Lyra Therapeutics's earnings are expected to grow from ($0.93) per share to ($0.58) per share in the next year. More Earnings Resources from MarketBeat Related Companies Femasys Earnings Allurion Technologies Earnings Nephros Earnings Retractable Technologies Earnings QT Imaging Earnings CollPlant Biotechnologies Earnings NEXGEL Earnings IRIDEX Earnings PetVivo Earnings Nexalin Technology Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout? This page (NASDAQ:LYRA) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
